
    
      This is an open-label, single-arm remote study to evaluate the effects of a Marine Lipid Oil
      Concentrate formulation on inflammation/discomfort and overall well-being in individuals who
      are generally healthy. Each subject will receive a specific dose of the study products to be
      taken once daily for a total of 60 days.

      Participants complete assessments and questionnaires.

      The primary objective is the evaluation of the change in the responses to the SF-36
      (Short-Form-36) Health Survey, Medical Symptoms questionnaire, Pain questionnaire and
      responses on an assessment form relative to baseline.

      Safety and tolerability will be evaluated through receipt of documentation and responses from
      the telephone contacts/emails as per protocol.
    
  